Trial WO29636

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

WO29636

Full title

a Phase III, open-Label, multicenter, randomized study of ATEZOLIZUMAB (ANTI-L1 Antibody) versus observation as adjuvant therapy in patients with PD-L1-selected, high-risk muscle-invasive bladder cancer after cystectomy

Responsible organization

Urologie MRI Ismaninger Str.22 81675 München Germany

Indications

Classification	Code	Description
-		Other tumors

Trial design

Phase

III

Status

Recruitment finished

Votes

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Therapy

Chemo,Zielgerichtet

Participants

	Function	Prename	Surname	Organization
	Responsible contact			Urologie MRI Ismaninger Str.22 81675 München Germany